Variant · Snv
IMPA1 NM_005536.4(IMPA1):c.325A>G (p.Ile109Val)
CI-VAR-00353661Explore in graph →p.Ile109ValNM_005536.4:c.325A>GClinVar 3341538
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 3341538 | Benign | criteria provided, single submitter | 1 | Uterine corpus endometrial carcinoma; Acute myeloid leukemia; Hepatocellular carcinoma; Malignant tumor of esophagus; Adrenocortical carcinoma, hereditary; Lung cancer; Clear cell carcinoma of kidney; Malignant lymphoma, large B-cell, diffuse; Ovarian serous cystadenocarcinoma; Thyroid cancer, nonmedullary, 1; Cervical cancer; Colorectal cancer; Chronic lymphocytic leukemia/small lymphocytic lymphoma; Sarcoma; Gastric cancer; Familial pancreatic carcinoma; Thymoma; Melanoma; Ovarian cancer; Lymphoma | germline | 2 | Jun 01, 2026 | clinvar |